BRIGHT program after head and neck cancer treatment
Part of Cancer clinical trials.
This trial tests a “renewed image” program (BRIGHT) compared with another option (AC) after you’ve finished treatment for certain head and neck cancers. It may help you with emotional well-being and adjustment after cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re over 18 years old.
- You previously had squamous cell cancer (a type of head/neck cancer) in places like the mouth, throat, voice box, nose/sinuses, major/minor salivary glands, or skin of the face/neck.
- You completed curative (intended to eliminate cancer) treatment—such as surgery and/or radiation—with your last cancer treatment finished between 6 weeks and 12 months before study enrollment.
- Your cancer is not detected at the time you join the study (cancer-free).
- You cannot be planning major head/neck surgery during the study period that requires at least a 3-day hospital stay.
- You must be willing and able to be randomly assigned to BRIGHT or AC, and you must score at least 22 on the IMAGE-HN questionnaire.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new program to help people who finished treatment for head and neck cancer stay on track with follow-up care. You may be able to join if you completed treatment 3 to 6 months ago and your cancer has not spread.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
This trial tests a navigation program (help from a care coordinator) versus usual care to help people start the recommended “next-step” treatments (like radiation, sometimes with chemo) on time after surgery. It’s for certain stages of squamous cell cancer in the head and neck area where late treatment could matter.
This study checks how people’s thinking and brain functioning change while they are getting radiation therapy for head and neck cancer. It uses simple computer tests and questionnaires to better understand who may be at risk for trouble thinking during treatment.
This trial studies whether a structured light-exposure routine can improve symptoms like fatigue and how survivors feel day to day. It is aimed at children and teens who have recovered from a non–high-risk type of brain tumor and have mild to moderate fatigue.
This trial tests two new drugs, BL-B01D1 and SI-B003, alone or together, for people with head and neck squamous cell carcinoma that has come back or spread. It may also include other solid tumors. The goal is to see if these drugs can shrink tumors or slow their growth.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.